XJF-24103-19255
2 vaccinations
2 coded responses
23 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 665 / KS
- Registered
- 2021-08-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-03
Registered in v-safe
-
2021-08-03
Dose 1 — Moderna
- 2021-08-03
- 2021-08-04
-
2021-08-05
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-08-06
- 2021-08-07
- 2021-08-08
- 2021-08-09
- 2021-08-10
- 2021-08-17
- 2021-08-24
- 2021-09-02
- 2021-09-07
-
2021-09-10
Dose 2 — Moderna
- 2021-09-14
- 2021-09-15
- 2021-09-16
- 2021-09-17
- 2021-09-24
- 2021-10-01
- 2021-10-08
- 2021-10-15
- 2021-10-22
-
2021-12-10
Survey response — 3 months, dose 2MedDRA: Respiratory tract congestion — Feeling: FairFree text: CongestionMedDRA releases: 2024-11 · check-in free text available
-
2022-03-11
Survey response — 6 months, dose 2MedDRA: Injection site pain — Feeling: GoodFree text: Soreness at the site of injectionMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-03 | Moderna | No |
| 2 | 2021-09-10 | Moderna | No |
Free text
Release 10 — 3 months, dose 2
Symptoms: Congestion
Release 11 — 6 months, dose 2
Symptoms: Soreness at the site of injection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Injection site pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release